2023
High-Level Drug-Resistant Mutations among HIV-1 Subtype A6 and CRF02_AG in Kazakhstan
Sanaubarova A, Pujol-Hodge E, Dzissyuk N, Lemey P, Vermund S, Brown A, Ali S. High-Level Drug-Resistant Mutations among HIV-1 Subtype A6 and CRF02_AG in Kazakhstan. Viruses 2023, 15: 1407. PMID: 37515095, PMCID: PMC10384832, DOI: 10.3390/v15071407.Peer-Reviewed Original ResearchConceptsAntiretroviral therapySubtype A6Drug-resistant mutationsDrug resistanceEffective antiretroviral therapySuppressive antiretroviral therapyAntiretroviral drug resistanceDrug resistance monitoringHigh-level drug resistanceDrug regimensHIV incidenceHIV epidemicHIV-1Sustained transmissionMolecular epidemiologySubtypesPLHIVHIVG190SDifferent mutational pathwaysMutationsK101ED67NHigh levelsA62V
1999
Prevention of mother-to-child transmission of HIV-1
Stringer J, Vermund S. Prevention of mother-to-child transmission of HIV-1. Current Opinion In Obstetrics & Gynecology 1999, 11: 427-434. PMID: 10526917, DOI: 10.1097/00001703-199910000-00003.Peer-Reviewed Original ResearchConceptsChild transmissionHIV-1Infant formula supplementationPrevention of motherHIV-1 transmissionCombination drug regimensResource-poor settingsFormula supplementationAntiretroviral therapyCesarean deliveryAntiretroviral agentsBreast feedingDrug regimensRandomized trialsPoor settingsInfectious diseasesInfant survivalSubstantial proportionPreliminary dataMothersLower ratesCost implicationsDeliveryRegimensPatients